Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 64 | BES2019 | Next issue

Belgian Endocrine Society 2019

BES 2019

Effect of nationwide reimbursement of sensor-augmented pump therapy in a paediatric type 1 diabetes population on HBA1C, hypoglycaemia and quality of life: the rescue-paediatrics study

ea0064010 | Effect of nationwide reimbursement of sensor-augmented pump therapy in a paediatric type 1 diabetes population on HBA1C, hypoglycaemia and quality of life: the rescue-paediatrics study | BES2019

Effect of nationwide reimbursement of sensor-augmented pump therapy in a paediatric type 1 diabetes population on HBA1C, hypoglycaemia and quality of life: The rescue-paediatrics study

De Ridder F , Charleer S , Jacobs S , Casteels K , Van Aken S , Vanbesien J , Gies I , Massa G , Lysy P , Logghe K , Lebrethon M-C , Depoorter S , Ledeganck K , Gillard P , De Block C , den Brinker M

Background: Long-term real-life data of sensor-augmented pump therapy (SAP) in paediatric type 1 diabetes (T1D) patients are lacking.Objectives: To assess the impact of SAP in a nationwide study of paediatric T1D patients on HbA1c, hypoglycaemia and quality of life until 24 months.Methods: Between December 2014 an...